Blow For Industry As GSK-Teva ‘Skinny Label’ Decision Upheld

 
• By David Wallace
  
Chisel Carve Out Wood
Generic drug labeling carve-outs are once again in the spotlight. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet